Skip to main content
. 2010 Apr 1;116(7):1767–1775. doi: 10.1002/cncr.24951

Table 2.

Toxicities (n = 51)a

Toxicity Grade (% of Patients)
1 2 3 4
Adrenal insufficiency 1 (2) 1 (2)
Anemia 28 (55) 14 (27) 4 (8) 1 (2)
Colitis 1 (2) 3 (6) 1 (2)
Confusion 3 (6) 1 (2)
Conjunctivitis 2 (4)
Dehydration 3 (6)
Diarrhea 6 (12) 3 (6) 8 (16)
Dyspnea 9 (18) 4 (8) 4 (8) 1 (2)
Fatigue 17 (33) 9 (18) 4 (8)
Hypothyroidism 1 (2)
Increased ALT 9 (18) 5 (10) 2 (4) 2 (4)
Increased AST 11 (22) 4 (8) 2 (4) 2 (4)
Increased bilirubin 2 (4) 2 (4)
Increased lipase 1 (2) 1 (2)
Infection 3 (6) 2 (4)
Leukopenia 10 (20) 1 (2) 1 (2)
Lymphopenia 6 (12) 9 (18) 9 (18)
Nausea/vomiting 15 (29) 4 (8) 2 (4)
Neutropenia 1 (2)
Pain 10 (20) 8 (16) 2 (4)
Pruritis 18 (35) 4 (8)
Rash 13 (25) 5 (10) 1 (2)
Thrombosis 1 (2) 1 (2)
Thrombocytopenia 1 (2) 2 (4) 2 (4) 1 (2)

ALT indicates alanine aminotransferase; AST, aspartate aminotransferase.

aToxicities were graded according to National Cancer Institute Common Terminology Criteria for Adverse Events (version 3.0).